Monday, June 29, 2026

Dongkoo Bio&Pharma Invests 1 Billion KRW in GenomAndCompany: What This Means for ADC Drug Development

Dongkoo Bio&Pharma invests 1 billion KRW in Genome & Company to enhance antibody and ADC drug development strategies.

China Gets a Promotion in North Korea’s Propaganda Pages

North Korea's media coverage of the Chinese Communist Party's anniversary shows subtle changes, hinting at improved relations between the two nations.

Discover the Benefits of Daewon Pharmaceutical’s New Liquid Health Supplements: A Guide to Sleep, Stress, and Immunity

Daewon Pharmaceutical launches a pop-up store at Olive Young, showcasing three innovative liquid health supplements for diverse needs.

Tag: L&K Biomed

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

L&K Biomed Reports First Human Use of BluEX-LT Spinal Implant at Major U.S. Hospital

L&K Biomed successfully completed the first surgery using its BluEX-LT implant, enhancing spinal deformity treatment and market expansion plans.

L&K BioMed Showcases Innovative Products at the AANS Conference in Texas

L&K BioMed showcased its products at the AANS conference, receiving positive feedback and interest for its cervical products, aiming to expand in the U.S. market.

Korean Spine-Implant Maker Targets Japan: L&K Biomed Showcases BluEX-LT at the Scoliosis Research Society Meeting

L&K Biomed showcased its products at the SRS conference in Japan, aiming to expand its market share in the APAC region, especially Japan.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.